Research at the interface of fundamental biology and translational application probes cancer as complex and adaptative system, shaped by tumor cells and their microenvironment. Experimental models, functional studies, and multi-omics analyses reveal how tumors evolve, adapt, and respond to therapies.
I have been exploring translational oncology for over 6 years, designing multidisciplinary programs, leading collaborative research groups, and coordinating projects that connect mechanistic studies with translational goals.
By combining organoid systems, co-cultures platforms, and preclinical models, my research uncovers cellular and molecular mechanisms linked to tumor progression, therapy resistance, and tumor-stoma interactions. Integrated functional studies and multi-omics analyses translate these findings into actionable insights, informing patient stratification and next-generation therapeutic development.
Standing at the crossroads of fundamental biology and clinical translation, I aim to turn complex discoveries into actionable advances for cancer therapy.
I have been exploring translational oncology for over 6 years, designing multidisciplinary programs, leading collaborative research groups, and coordinating projects that connect mechanistic studies with translational goals.
By combining organoid systems, co-cultures platforms, and preclinical models, my research uncovers cellular and molecular mechanisms linked to tumor progression, therapy resistance, and tumor-stoma interactions. Integrated functional studies and multi-omics analyses translate these findings into actionable insights, informing patient stratification and next-generation therapeutic development.
Standing at the crossroads of fundamental biology and clinical translation, I aim to turn complex discoveries into actionable advances for cancer therapy.
Open to scientific discussion, collaboration, and new challenges.